Papillary Cystadenocarcinoma

This is a type of cancer that starts in the cells that line the inside of certain organs, like the pancreas or gallbladder. The cancer cells grow into finger-like projections or a solid lump. It's a specific kind of adenocarcinoma, which is a common type of cancer.

Condition

What people with Papillary Cystadenocarcinoma report

Every report comes from a Lived member, sent anonymously.

NameHow it went

No reports yet

Add what worked for you with the search bar below

About Papillary Cystadenocarcinoma

What It Is

Papillary cystadenocarcinoma is a cancer named for how it looks under a microscope, not for where in the body it starts. The name breaks into parts: "cyst" for fluid-filled spaces, "adeno" for gland-forming cells, "carcinoma" for a cancer of the tissue that lines organs, and "papillary" for the small finger-like growths that project from that lining. A pathologist (a doctor who diagnoses disease by examining tissue) uses it to describe a tumor's pattern. It is not one disease with a single course or treatment. The same pattern turns up in quite different cancers. In the ovary, and in the closely related fallopian tubes, abdominal lining (peritoneum) and lining of the uterus, it is typical of serous cancers. Serous cancer is the most common type of ovarian cancer and is often aggressive. In the salivary glands, papillary cystadenocarcinoma is a rare cancer that usually grows slowly, most often as a lump in the parotid gland in front of the ear. Because outlook and treatment depend so much on the organ and on how abnormal the cells look (the grade), the most important detail in a diagnosis is where the tumor started. Newer pathology reports often use a different name for the same tumor, such as serous carcinoma for the ovarian type, so the label may change without the diagnosis changing.

Causes & Risk Factors

For the ovarian type, cancer develops from changes in the DNA of cells. Most of these changes happen during a person's lifetime, but some are inherited. Inherited changes in the BRCA1 or BRCA2 genes (which normally help cells repair damaged DNA), or Lynch syndrome (an inherited condition that also raises the risk of colon cancer), raise the risk considerably, which is why ovarian cancer that runs in a family is taken seriously. Other risk factors for ovarian cancer in general include older age, especially after menopause, a mother, sister or daughter with ovarian cancer, endometriosis, past use of hormone therapy for menopause, obesity, being tall and never having been pregnant. These factors make the cancer more likely across a population. They do not mean that any one of them caused an individual's cancer, and many people who develop it have none of them. For the salivary gland type, no specific cause has been identified. It is found mostly in people over 50.

How It's Diagnosed

This diagnosis is always made by examining tissue under a microscope. Scans and blood tests can raise suspicion and show how far a tumor extends, but they cannot name the cell pattern. When an ovarian cancer is suspected, assessment usually includes a pelvic exam, ultrasound and often a CT scan. A CA-125 blood test may also be done. CA-125 is a protein that many ovarian cancers release into the blood, but it can also rise with noncancerous conditions such as endometriosis, so a high level is a clue rather than a diagnosis. The tissue sample is often taken during surgery to remove the tumor, and the same operation helps stage the cancer, meaning it shows how far the cancer has spread. Genetic testing for BRCA and related changes is usually recommended, both because it affects treatment and because relatives may want to know their own risk. For a salivary gland lump, an MRI shows whether the tumor is solid or cystic and whether it has grown into nearby tissue. A fine-needle aspiration, which draws cells out with a thin needle, can often show that a lump is cancer. The exact type is frequently confirmed only once the whole tumor has been removed, because the pathologist needs to see it invading surrounding tissue to tell it apart from cystadenoma, its benign (noncancerous) counterpart.

Treatment Options

Treatment follows the organ where the cancer started, so the two main forms are handled very differently. For ovarian, fallopian tube and peritoneal cancers, most people have surgery to remove as much of the tumor as possible. This often includes removing the uterus, both ovaries and fallopian tubes, and the omentum (a layer of tissue inside the abdomen), with lymph nodes sampled to check for spread. Chemotherapy, usually a platinum-based combination, is given after surgery, and sometimes first to shrink the cancer and make surgery more effective. Some people then take maintenance treatment to lower the chance of the cancer returning. PARP inhibitors, such as olaparib (Lynparza) and niraparib (Zejula), are daily pills that block a repair system cancer cells rely on. They are approved for people whose cancer responded to platinum chemotherapy and whose tumor has BRCA changes or a related repair defect, which is one reason genetic and tumor testing matters. Bevacizumab (Avastin), an infusion that blocks the growth of blood vessels feeding a tumor, may be added to chemotherapy or maintenance for some people. For the salivary gland form, the main treatment is complete surgical removal of the tumor, which for the parotid usually means removing the outer part of the gland. When a tumor is high grade, lymph nodes in the neck are also removed. Because this form is so rare, recommendations come from case reports and small series rather than clinical trials. For either form, clinical trials may offer access to newer treatments, and it is reasonable to ask about them at any stage.

What to Expect

For the ovarian type, outlook depends mainly on the stage at diagnosis, whether all visible cancer could be removed, whether the tumor carries BRCA changes, and a person's age and overall health. Because early stages often cause few symptoms, many people are diagnosed once the cancer has already spread within the abdomen. Treatment can still bring long periods with no sign of disease, but this cancer often returns, so follow-up continues for years, with regular exams, often CA-125 blood tests, and scans when needed. A recurrence can be treated again, often with further chemotherapy and sometimes maintenance medicines. Surgery and chemotherapy also have side effects that take time to recover from, and the care team can help plan for work, family and daily life during treatment. For the salivary gland type, the outlook after complete removal is generally good, since most of these tumors are low grade and slow growing. A small number behave more aggressively and spread to neck lymph nodes, and spread to the lungs has been reported years after surgery. For that reason, long-term follow-up is advised.

When to Seek Help

See a doctor if pain, swelling or pressure in the abdomen or pelvis, bloating, feeling full quickly, or a sudden or frequent urge to urinate keeps going or gets worse over a few weeks. These symptoms usually have other causes, but persistent ones deserve an examination. A lump in front of the ear, along the jaw or inside the mouth that does not go away also warrants evaluation, even if it is painless. After treatment, contact your care team promptly about new or returning symptoms, such as growing abdominal swelling or bloating, or a new lump, rather than waiting for the next scheduled visit. With the ovarian type, repeated vomiting, being unable to pass stool or gas, or severe or worsening belly pain with swelling can mean the bowel is blocked, a known complication when this cancer spreads within the abdomen. These signs need same-day urgent care: call the care team's urgent line or go to an emergency department.

Questions to Ask Your Doctor

  1. 1.Where did this tumor start, what is its grade, and does the pathology report use a newer name for it?
  2. 2.What stage is the cancer, and what is the goal of the treatment you are recommending?
  3. 3.Should I have genetic testing or tumor testing, and what would the results mean for my treatment and my family?
  4. 4.What will follow-up involve after treatment, and which symptoms should prompt me to call before my next visit?
  5. 5.Are there clinical trials that would make sense for me?

Last reviewed • Oct 2026

Educational content, not medical advice.